Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Preview

Cluster news

Major achievement for inflammation research in Northern Germany: The Cluster of Excellence PMI secures renewed funding

The Cluster of Excellence PMI will receive funding for another seven years, enabling it to continue its successful research into chronic inflammatory diseases.

 

 
[EN]

World IBD Day: PMI and Kiel University raise awareness of chronic inflammatory bowel disease

With light installations and a music video, the Cluster of Excellence PMI and Kiel University are drawing attention to chronic inflammatory bowel diseases and the associated need for research.

 

 
[EN]

Faster recovery from COVID-19 through targeted use of high-dose vitamin B3 in the intestine

Placebo-controlled clinical trial with 900 COVID-19 patients shows success of a new patent-protected compound from the Cluster of Excellence PMI in Kiel (Germany).

 
Ein Klemmbrett

Initiative for gender- and diversity-sensitive precision medicine in Kiel and Lübeck

In a data sharing statement, university medicine in Kiel and Lübeck commits to providing its clinical study data differentiated by gender and diversity characteristics.